STEMLINE THERAPEUTICS BV
ItalyAll drugs from this manufacturer
-
This medicine is used to treat adults with blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare type of cancer that affects immune cells and can involve organs such as the skin, bone marrow, and lymph nodes.
Dosage form: solution for infusion, concentrate
Active substance Dosage tagraxofusp - ATC: L01XX67
-
It is used to treat adults with multiple myeloma that has recurred after treatment. It can be used in combination with other medicines (bortezomib and dexamethasone) or alone with dexamethasone, depending on the type of previous treatment received by the patient.
Dosage form: tablets, film-coated
Active substance Dosage selinexor - ATC: L01XX66
-
This medicinal product is used to treat postmenopausal women and adult men with a specific type of advanced or metastatic breast cancer. It is indicated for estrogen receptor (ER)-positive and HER2-negative tumors in patients presenting ESR1 gene mutations who have not responded to other hormonal treatments.
Dosage form: tablets, film-coated
Active substance Dosage elacestrant dihydrochloride - ATC: L02BA04